Illa I - Search Results

1

[Eaton-Lambert syndrome. Long-term treatment with corticoids].

Illa I, Pradas J, Vázquez J, Codina M. Illa I, et al. Med Clin (Barc). 1986 May 10;86(18):782. Med Clin (Barc). 1986. PMID: 3736183 Spanish. No abstract available.

2

["Seronegative" myasthenia gravis and antiMuSK positive antibodies: description of Spanish series].

Illa I, Díaz-Manera JA, Juárez C, Rojas-García R, Molina-Porcel L, Aleu A, Pradas J, Gallardo E. Illa I, et al. Med Clin (Barc). 2005 Jun 18;125(3):100-2. doi: 10.1157/13076937. Med Clin (Barc). 2005. PMID: 15989843 Spanish.

3

IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.

Illa I. Illa I. J Neurol. 2005 May;252 Suppl 1:I14-8. doi: 10.1007/s00415-005-1104-5. J Neurol. 2005. PMID: 15959667 Review.

4

[Glycogenosis type V of adults: muscle phosphorylase deficiency].

Coll Cantí J, Illa I, Beleta J, Anglada A, Pradas J, González Sastre F, Grau Veciana JM, Gella FJ. Coll Cantí J, et al. Among authors: illa i. Med Clin (Barc). 1986 Mar 1;86(8):335-8. Med Clin (Barc). 1986. PMID: 3458989 Spanish. No abstract available.

5

[Predictive factors of the response to treatment of myasthenia gravis with prednisone].

Pradas J, Illa I. Pradas J, et al. Among authors: illa i. Neurologia. 1990 Jan;5(1):11-3. Neurologia. 1990. PMID: 2361025 Spanish.

6

Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.

Querol L, Nogales-Gadea G, Rojas-Garcia R, Diaz-Manera J, Pardo J, Ortega-Moreno A, Sedano MJ, Gallardo E, Berciano J, Blesa R, Dalmau J, Illa I. Querol L, et al. Among authors: illa i. Neurology. 2014 Mar 11;82(10):879-86. doi: 10.1212/WNL.0000000000000205. Epub 2014 Feb 12. Neurology. 2014. PMID: 24523485 Free PMC article.

7

Diagnostic utility of cortactin antibodies in myasthenia gravis.

Illa I, Cortés-Vicente E, Martínez MÁ, Gallardo E. Illa I, et al. Ann N Y Acad Sci. 2018 Jan;1412(1):90-94. doi: 10.1111/nyas.13502. Epub 2017 Oct 25. Ann N Y Acad Sci. 2018. PMID: 29068555 Review.

8

Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin.

Cortés-Vicente E, Gallardo E, Martínez MÁ, Díaz-Manera J, Querol L, Rojas-García R, Illa I. Cortés-Vicente E, et al. Among authors: illa i. JAMA Neurol. 2016 Sep 1;73(9):1099-104. doi: 10.1001/jamaneurol.2016.2032. JAMA Neurol. 2016. PMID: 27379450

9

Clinical and serological features of acute sensory ataxic neuropathy with antiganglioside antibodies.

Rojas-García R, Querol L, Gallardo E, De Luna Salva N, Juarez C, Garces M, Fages E, Casasnovas C, Illa I. Rojas-García R, et al. Among authors: illa i. J Peripher Nerv Syst. 2012 Jun;17(2):158-68. doi: 10.1111/j.1529-8027.2012.00407.x. J Peripher Nerv Syst. 2012. PMID: 22734901

10

Bulbar involvement in patients with antiganglioside antibodies against NeuNAc(alpha2-3)Gal.

Rojas-Garcia R, Gallardo E, De Luna N, Juarez C, Martinez-Hernandez E, Carvajal A, Casasnovas C, Fages E, Davila-González P, Illa I. Rojas-Garcia R, et al. Among authors: illa i. J Neurol Neurosurg Psychiatry. 2010 Jun;81(6):623-8. doi: 10.1136/jnnp.2009.183517. Epub 2009 Sep 2. J Neurol Neurosurg Psychiatry. 2010. PMID: 19726412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results